Patents by Inventor Charles Paul Plested

Charles Paul Plested has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
    Patent number: 11065341
    Abstract: The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylated ganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: July 20, 2021
    Assignee: Children's Hospital & Research Center at Oakland
    Inventors: Gregory R. Moe, Charles Paul Plested
  • DE-N-Acetyl Sialic Acid Antigens, Antibodies Thereto, and Methods of Use in Cancer Therapy
    Publication number: 20180154016
    Abstract: The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylated ganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.
    Type: Application
    Filed: December 12, 2017
    Publication date: June 7, 2018
    Inventors: Gregory R. Moe, Charles Paul Plested
  • DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
    Patent number: 9872921
    Abstract: The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylated ganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: January 23, 2018
    Assignee: CHILDREN'S HOSPITAL & RESEARCH CENTER AT OAKLAND
    Inventors: Gregory R. Moe, Charles Paul Plested
  • DE-N-Acetyl Sialic Acid Antigens, Antibodies Thereto, and Methods of Use in Cancer Therapy
    Publication number: 20160184450
    Abstract: The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylated ganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.
    Type: Application
    Filed: June 17, 2015
    Publication date: June 30, 2016
    Inventors: Gregory R. Moe, CHARLES PAUL PLESTED
  • De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
    Patent number: 9089513
    Abstract: The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylated ganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.
    Type: Grant
    Filed: February 24, 2012
    Date of Patent: July 28, 2015
    Assignee: Children's Hospital & Research Center Oakland
    Inventors: Gregory R. Moe, Charles Paul Plested
  • DE-N-Acetyl Sialic Acid Antigens, Antibodies Thereto, and Methods of Use in Cancer Therapy
    Publication number: 20120219560
    Abstract: The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylated ganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.
    Type: Application
    Filed: February 24, 2012
    Publication date: August 30, 2012
    Inventors: GREGORY R. MOE, Charles Paul Plested
  • De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
    Patent number: 8148335
    Abstract: The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylated ganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.
    Type: Grant
    Filed: December 22, 2006
    Date of Patent: April 3, 2012
    Assignee: Children's Hospital & Research Center Oakland
    Inventors: Gregory R. Moe, Charles Paul Plested
  • De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
    Publication number: 20100260762
    Abstract: The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface de-N-acetylated sialic acid antigen, e.g., an at least partially de-N-acetylated ganglioside and/or a de-N-acetylated sialic acid-modified cell surface protein.
    Type: Application
    Filed: December 22, 2006
    Publication date: October 14, 2010
    Inventors: Gregory R. Moe, Charles Paul Plested